These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1652256)

  • 41. RoBo-1, a novel member of the urokinase plasminogen activator receptor/CD59/Ly-6/snake toxin family selectively expressed in rat bone and growth plate cartilage.
    Noel LS; Champion BR; Holley CL; Simmons CJ; Morris DC; Payne JA; Lean JM; Chambers TJ; Zaman G; Lanyon LE; Suva LJ; Miller LR
    J Biol Chem; 1998 Feb; 273(7):3878-83. PubMed ID: 9461570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A urokinase receptor-associated protein with specific collagen binding properties.
    Behrendt N; Jensen ON; Engelholm LH; Mørtz E; Mann M; Danø K
    J Biol Chem; 2000 Jan; 275(3):1993-2002. PubMed ID: 10636902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antisense oligonucleotides against the urokinase receptor: a therapeutic strategy for the control of cell invasion in rheumatoid arthritis and cancer.
    Del Rosso M; Fibbi G; Pucci M; Cerinic MM
    Clin Exp Rheumatol; 1998; 16(4):389-93. PubMed ID: 9706415
    [No Abstract]   [Full Text] [Related]  

  • 44. Nucleotide and deduced amino acid sequences of baboon urokinase-type plasminogen activator.
    Au YP; Wang TW; Clowes AW
    Nucleic Acids Res; 1990 Jun; 18(11):3411. PubMed ID: 2113276
    [No Abstract]   [Full Text] [Related]  

  • 45. Japanese case of Mal de Meleda with a novel missense mutation of p.Thr52Ala in the second protruding finger of secreted Ly-6/uPAR-related protein 1.
    Kunisada M; Yamanishi K; Nishigori C
    J Dermatol; 2019 Jul; 46(7):e235-e237. PubMed ID: 30663803
    [No Abstract]   [Full Text] [Related]  

  • 46. Enhanced expression of an antibody-targeted plasminogen activator in Escherichia coli by fusion to decorsin.
    Yu M; Yu M; Ru B
    Biotechnol Lett; 2004 May; 26(9):717-21. PubMed ID: 15195971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Urokinase-type plasminogen activator and its specific receptor in high metastatic and non-metastatic cell lines derived from human lung adenocarcinoma.
    Hagiya Y; Fukao H; Ueshima S; Inufusa H; Izaki S; Kamiishi H; Okada K; Matsuo O
    Thromb Res; 1992 Feb; 65(3):449-56. PubMed ID: 1321513
    [No Abstract]   [Full Text] [Related]  

  • 48. Characterization and function of human Ly-6/uPAR molecules.
    Kong HK; Park JH
    BMB Rep; 2012 Nov; 45(11):595-603. PubMed ID: 23186997
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Jafar Hussain HM; Khan R; Li C; Aftab A; Muneer I; Wahab F; Wu L; Jiang X; Xu P
    Ann Clin Lab Sci; 2019 Nov; 49(6):710-721. PubMed ID: 31882421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assignment of the human urokinase receptor gene (PLAUR) to 19q13.
    Vagnarelli P; Raimondi E; Mazzieri R; De Carli L; Mignatti P
    Cytogenet Cell Genet; 1992; 60(3-4):197-9. PubMed ID: 1324136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conservation and potential role of RNA-instability motifs in urokinase gene 3'-untranslated sequences.
    Henderson BR; Kefford RF
    J Natl Cancer Inst; 1991 Aug; 83(15):1103-4. PubMed ID: 1714963
    [No Abstract]   [Full Text] [Related]  

  • 52. Emergence of the Ly-6 superfamily of GPI-anchored molecules.
    Williams AF
    Cell Biol Int Rep; 1991 Sep; 15(9):769-77. PubMed ID: 1724949
    [No Abstract]   [Full Text] [Related]  

  • 53. PATE gene clusters code for multiple, secreted TFP/Ly-6/uPAR proteins that are expressed in reproductive and neuron-rich tissues and possess neuromodulatory activity.
    Levitin F; Weiss M; Hahn Y; Stern O; Papke RL; Matusik R; Nandana SR; Ziv R; Pichinuk E; Salame S; Bera T; Vincent J; Lee B; Pastan I; Wreschner DH
    J Biol Chem; 2008 Jun; 283(24):16928-39. PubMed ID: 18387948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasminogen activator-dependent pericellular proteolysis.
    Scully MF
    Br J Haematol; 1991 Dec; 79(4):537-43. PubMed ID: 1663384
    [No Abstract]   [Full Text] [Related]  

  • 55. Isolation of a plasminogen activator (urokinase) from urine.
    PLOUG J; KJELDGAARD NO
    Arch Biochem Biophys; 1956 Jun; 62(2):500-1. PubMed ID: 13328139
    [No Abstract]   [Full Text] [Related]  

  • 56. Urokinase receptor and colorectal cancer survival.
    Ganesh S; Sier CF; Heerding MM; Griffioen G; Lamers CB; Verspaget HW
    Lancet; 1994 Aug; 344(8919):401-2. PubMed ID: 7914317
    [No Abstract]   [Full Text] [Related]  

  • 57. Three-Finger Proteins from the Ly6/uPAR Family: Functional Diversity within One Structural Motif.
    Vasilyeva NA; Loktyushov EV; Bychkov ML; Shenkarev ZO; Lyukmanova EN
    Biochemistry (Mosc); 2017 Dec; 82(13):1702-1715. PubMed ID: 29523067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urokinase and the US Food and Drug Administration.
    Ouriel K
    J Vasc Surg; 1999 Nov; 30(5):957-8. PubMed ID: 10550197
    [No Abstract]   [Full Text] [Related]  

  • 59. Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.
    Zhai BT; Tian H; Sun J; Zou JB; Zhang XF; Cheng JX; Shi YJ; Fan Y; Guo DY
    J Transl Med; 2022 Mar; 20(1):135. PubMed ID: 35303878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The regulatory mechanism of the LY6K gene expression in human breast cancer cells.
    Kong HK; Yoon S; Park JH
    J Biol Chem; 2012 Nov; 287(46):38889-900. PubMed ID: 22988241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.